Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure

This publication has 21 references indexed in Scilit:

• Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure
  American Heart Journal, 1984
• Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients
  Journal of the American College of Cardiology, 1984
• Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance
  The American Journal of Cardiology, 1984
• Left ventricular end-systolic pressure-volume relation
  The American Journal of Cardiology, 1983
• The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
  Circulation, 1983
• Characterization of the Cardiovascular Activities of a New Cardiotonic Agent, MDL 17043 (1,3-Dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)
  Journal of Cardiovascular Pharmacology, 1982
• Exercise-induced alterations in left ventricular volumes and the pressure-volume relationship: a sensitive indicator of left ventricular dysfunction in patients with coronary artery disease.
  Circulation, 1981
• Aortic input impedance in heart failure.
  Circulation, 1978
• The role of vasodilator therapy in heart failure
  Progress in Cardiovascular Diseases, 1977
• Load Independence of the Instantaneous Pressure-Volume Ratio of the Canine Left Ventricle and Effects of Epinephrine and Heart Rate on the Ratio
  Circulation Research, 1973